Biocept, Inc. , a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample.
Biocept stock last closed at $2.16, down 6.9% from the previous day, and has decreased 94.86% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.92 percentage points. Biocept stock is currently +5.37% from its 52-week low of $2.05, and -95.47% from its 52-week high of $47.70.
As of May 26, 2023, there are 592,906 BIOC shares outstanding. The market value of BIOC is $1.28M. In the last 24 hours, 316,432 BIOC shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy BIOC stock.
Based on our experience, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal info so you are able to invest in BIOC stock today.
Now that you have created your account on the best stock app, you need to deposit funds:
Watch the tutorial below for more details depositing funds into your investment account.
Once you have chosen the best place to buy Biocept stock, it's very important to evaluate their stock prior to investing, so you actually wrap your head around the risk and upside.
WallStreetZen was created to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on BIOC's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge BIOC's true value.
Using relative valuations ratios:
You can do additional valuation research on BIOC's stock here.
You can dig deeper into what analysts are projecting on the Biocept stock forecast page.
Last year, BIOC revenue was $11.38M. In the past 5 year, BIOC's revenue has increased by 22.1% per year. This was faster than the Diagnostics & Research industry average of 15.01%.
Learn more about BIOC's earnings and revenue performance here.
Over the last year, executives and large shareholders at BIOC have not bought or sold any shares.
Learn more about who owns BIOC stock here.
No, Biocept doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two main options:
Click the Open button and your broker will place the order.
If you need more help with buying stocks on eToro, click the how to video below:
Now that you own some BIOC stock, you'll want to keep up with your new company.
Add BIOC to a watchlist to track the most important metrics related to your BIOC stock.
To reiterate, here are the 6 steps to buy Biocept stock:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Biocept, add BIOC to your watchlist by clicking the button below.